Joe Biden’s administration could bring new leadership at the Centers for Medicare and Medicaid Services, possibly presenting more challenges influencing regulations.
Physicians can take steps to reduce their risk of being sued by having a low threshold for discharging angry patients from their practice and carefully documenting all discussions and interactions with these patients.
Mitomycin gel (Jelmyto), which received FDA approval in April 2020, addresses a need for a better way to treat low-grade UTUC, a malignancy that is challenging to manage.